<DOC>
	<DOCNO>NCT00486226</DOCNO>
	<brief_summary>The objective registry evaluate real world safety performance CORDIS ENTERPRISE™ Vascular Reconstruction Device Delivery System ( VRD ) facilitate endovascular coil embolization intracranial aneurysm .</brief_summary>
	<brief_title>The Registry Study Safety Performance CORDIS Vascular Reconstruction Device Delivery System</brief_title>
	<detailed_description>The data collect consecutive subject treat commercially available product follow standard clinical practice . This registry limit subject receive CORDIS ENTERPRISE™ VRD index procedure . While limited inclusion exclusion criterion specify , uniform , complete accurate data collect peri-procedurally , index hospitalization , follow-up 6 month . All subject treat accord Instruction For Use ( IFU ) include conduct VRD placement , coil procedure , application antiplatelet medication medical therapy provide accord local usual practice .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>The subject must &gt; = 18 year age less 80 year . Diagnosis rupture ( Hunt Hess Grade I III ) unruptured intracranial aneurysm time treatment Subject ( his/her legal representative ) provide write informed consent use his/her periprocedural followup data Diagnosis Hunt Hess Grade IV V subarachnoid hemorrhage time treatment Severe comorbidity associate lifeexpectancy less six month Poor neurological status baseline Known allergy Nitinol metal Known allergy aspirin , heparin , ticlopidine , clopidogrel unable unwilling tolerate therapy Participation investigational drug another device study allow write approval coordinate investigator Cordis Medical Monitor . Implantation intracranial stent associate symptomatic distribution within 12 week prior index procedure Implantation carotid stent associate symptomatic distribution within 12 week prior index procedure Atrial fibrillation know cardiac disorder likely associate cardioembolic symptom .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>